Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)
Memorial Sloan Kettering Cancer Center · NCT07144800
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 1319
- US sites recruiting
- 1
- Study start
- August 22, 2025
- Record last updated
- October 8, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this study is to determine the most effective family-centered intervention (FCI) for weight loss and obesity prevention in Hispanic families. FCI is a type of program that involves family (such as parents and caregivers) supporting their children to promote healthy habits.
Being studied: Parent Weekly Individual Telephone Support; Child Education; Parent Initial Counseling; Parent Monthly Group Support
Conditions: Obesity; Child Obesity; Weight Loss
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
Phase 1
- Age >= 18 years (per self-report)
- Self-identifies as Hispanic/Latino (per self-report)
- Seeking, or has used, services at the VDS or MHU (per self-report)
- Is the parent or primary caregiver for at least one child aged 8-12 living in their household (per self-report)
- Screens as obese (BMI > 30 kg/m2) or overweight (BMI of 25 - 29.9 kg/m2) (per height and weight measurement in person or per self-report)
- Owns a cell phone capable of receiving text messages (per self-report)
- Owns an internet connected device (e.g. cell phone, tablet, etc.) capable of conducting videoconference calls (per self-report)
- Agrees to be audio-recorded (per self-report)
Phase 2 (parent participants)
- Age >= 18 years (per self-report)
- Self-identifies as Hispanic/Latino (per self-report)
- Seeking, or has used, services at the VDS or MHU (per self-report)
- Is the parent or primary caregiver for at least one child aged 8-12 living in their household (per self-report)
- Screens as obese (BMI > 30 kg/m2) or overweight (BMI of 25 - 29.9 kg/m2) (per height and weight measurement in person or remotely)
- Owns a cell phone capable of receiving text messages (per self-report)
- Owns an internet connected device (e.g. cell phone, tablet, etc.) capable of conducting videoconference calls (per self-report)
- Agrees to be audio-recorded (per self-report)
Phase 2 (child participants)
- Age 8-12 years (per parent self-report)
- Has a parent or primary caregiver who is eligible and participating in Phase 2 (per parent self-report)
Exclusion Criteria
Phase 1
- Is pregnant or might be pregnant (per self-report)
- Presence of a chronic disease such as cancer, kidney disease, liver disease, etc. (individuals with hypertension and diabetes mellitus may still participate) that may affect diet and study participation (per self-report)
- Has dietary restrictions, i.e. liquid diet, that may affect diet and study participation (per self-report)
- Has a household member who has already participated or agreed to participate in this study program (per self-report)
- Prior participation in one of our preliminary studies, e.g., COMIDA, SANOS, Family COMIDA (per self-report) and any related focus groups
- Works for or with the VDS or MHU (per self-report)
- Presence of cognitive impairment disorder (i.e., delirium or dementia) sufficient to preclude meaningful informed consent and/or data collection (per study team)
Phase 2 (parent participant)
- Is pregnant or might be pregnant (per self-report)
- For women, is lactating (per self-report)
- Presence of a chronic disease such as cancer, kidney disease, liver disease, etc. (individuals with hypertension and diabetes mellitus may still participate) that may affect diet and study participation (per self-report)
- Has dietary restrictions, i.e., liquid diet, that may affect diet and study participation (per self-report)
- Has physical activity restrictions, i.e., handicapped or mobility issues, that may affect physical activity participation (increasing step counts; per self-report)
- Has a household member who has already participated or agreed to participate in this study program (per self-report)
- Prior participation in one of our preliminary studies, e.g., COMIDA, SANOS, Family COMIDA (per self-report) and any related focus groups
- Works for or with the VDS or MHU (per self-report)
- Presence of cognitive impairment disorder (i.e., delirium or dementia) sufficient to preclude meaningful informed consent and/or data collection (per study team)
- Has been prescribed Ozempic, Wegovy, Mounjaro, Rybelsus, Trulicity (or other GLP 1 receptor agonist), or any other drug to treat obesity (per self-report) or (if previously prescribed) 7 weeks have not passed since the last dose was taken.
- Has undergone weight loss/bariatric surgery (RYBG, gastric banding, sleeve gastrectomy, balloon, etc.) or is planning to undergo such surgery in the next 12 months (per self-report)
Phase 2 (child participant)
- Has dietary restrictions, i.e., liquid diet, that may affect diet and study participation (per parent self-report)
- Has physical activity restrictions, i.e., handicapped or mobility issues, that may affect physical activity participation (per parent self-report)
- Has an eating disorder (per parent self-report)
- Is underweight (per parent self-report)
Recruiting US locations
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, NY 10065
Site contact: Jennifer Leng, MD, MPH · 646-888-8057
Study contacts (from the official record)
- Jennifer Leng, MD, MPH · 646-888-8057 · lengj@mskcc.org
- Francesca Gany, MD, MS · 646-888-8054 · ganyf@mskcc.org
Similar studies in New York
All weight loss studies in New York →- RecruitingHealthy volunteersPhase 1
Alpelisib Challenge Test (ACT)
Columbia University
- Location
- New York, NY
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersPhase 1
Human Models of Selective Insulin Resistance: Alpelisib, Part I
Columbia University
- Location
- New York, NY
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersPhase 3
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Location
- The Bronx, NY + 55 other US sites
- Eligibility basics
- Ages 18–79
- RecruitingHealthy volunteers
Hunger Perception and Weight-Related Outcomes Following Use of a Leptin-Supporting Dietary Supplement
Efforia, Inc
- Location
- New York, NY
- Eligibility basics
- Ages 18+